Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | TNNI3 | P19429 | 1/20 | 0.36 |
| ▸ | TNNT2 | P45379 | 1/20 | 0.36 |
| ▸ | TNNC1 | P63316 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 3/20 | 0.32 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.32 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29853795 | 1.00 | IDO1 (0.45) | IDO1KDM4EMEN1KMT2ATNNI3 | |
| SCHEMBL17763337 | 0.87 | CYP3A4 (0.46) | IDO1KDM4EMEN1KMT2ATNNI3 | |
| SCHEMBL4644749 | 0.81 | HTR2A (0.60) | KDM4EMEN1KMT2AALDH1A1HSD17B10 | |
| SCHEMBL30661084 | 0.75 | FOLH1 (0.46) | IDO1KDM4EMEN1KMT2ATNNI3 | |
| SCHEMBL11822029 | 0.71 | IDO1 (0.48) | IDO1KDM4EMEN1KMT2AALDH1A1 | |
| SCHEMBL11289240 | 0.70 | HSD17B10 (0.46) | KDM4EALDH1A1HSD17B10CYP2A6TSHR | |
| SCHEMBL10079056 | 0.69 | FOLH1 (0.42) | IDO1KDM4EMEN1KMT2ATNNI3 | |
| SCHEMBL13430090 | 0.68 | FOLH1 (0.41) | KDM4EMEN1KMT2ATNNI3TNNT2 | |
| SCHEMBL2879124 | 0.67 | IDO1 (0.50) | IDO1KDM4ETDP1CYP1A2CYP2C19 | |
| SCHEMBL1719724 | 0.67 | ALDH1A1 (0.45) | IDO1MEN1KMT2ATNNI3TNNT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 451 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017025244-A1 | COSMETIC PROCESS FOR TREATING KERATIN MATERIALS | L'OREAL (FR) | 2017-02-16 | — | — | WO | claimed |
| JP-2113027-A | — | — | None | — | — | JP | disclosed |
| JP-2107611-A | — | — | None | — | — | JP | disclosed |
| US-6391433-B1 | — | — | None | — | — | US | disclosed |
| US-12606692-B2 | Spectacle lens | HOYA LENS THAILAND LTD. (TH) | 2026-04-21 | — | — | US | disclosed |
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | KUREHA CORPORATION (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-3778170-B1 | METHOD FOR MANUFACTURING OPTICAL MEMBER | HOYA LENS THAILAND LTD (TH) | 2026-01-28 | — | — | EP | disclosed |
| EP-4640735-A1 | CURABLE RESIN COMPOSITION AND PROCESSED PRODUCT OF SAME | ThreeBond Co., Ltd. (JP) | 2025-10-29 | — | — | EP | disclosed |
| EP-4613263-A1 | PHOTOCURABLE COMPOSITION FOR NAILS OR ARTIFICIAL NAILS | ThreeBond Co., Ltd. (JP) | 2025-09-10 | — | — | EP | disclosed |
| US-5013496-A | Polyurethane or polythiourethane | MITSUI TOATSU CHEMICALS, INC. (JP) | 1991-05-07 | — | — | US | disclosed |
| EP-0422836-A2 | Resin for urethane lenses, lenses comprising the resin, and a process for preparation of the resin and the lenses | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1991-04-17 | — | — | EP | disclosed |
| EP-0394495-A1 | 4,4'-BIS(METHACRYLOYLTHIO)DIPHENYL SULFIDE AND CURABLE COMPOSITION CONTAINING SAME | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 1990-10-31 | — | — | EP | disclosed |
| EP-0374258-A1 | HIGH REFRACTIVE INDEX LENS AND METHOD FOR ITS PRODUCTION | MITSUI CHEMICALS, INC. (JP) | 1990-06-27 | — | — | EP | disclosed |
| JP-H02113027-A | CURABLE COMPOSITION | SHOWA DENKO KK | 1990-04-25 | — | — | JP | disclosed |
| JP-H02107611-A | CURABLE COMPOSITION | SHOWA DENKO KK | 1990-04-19 | — | — | JP | disclosed |
| EP-0351073-A2 | Lens comprising a resin having a large refractive index and process for preparing the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-01-17 | — | — | EP | disclosed |
| EP-0330363-A2 | Highly-refractive plastic lens and process for making the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-30 | — | — | EP | disclosed |
| US-3979369-A | DIENE POLYMER | MONSANTO COMPANY (US) | 1976-09-07 | — | — | US | disclosed |
| US-3974163-A | VULCANIZATION INHIBITOR | MONSANTO COMPANY (US) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062548-A1 | RUBBER-BONDED CELLULOSE FIBERS AND MANUFACTURING METHOD THEREFOR, RESIN COMPOSITION AND MANUFACTURING METHOD THEREFOR, AND CURABLE RESIN COMPOSITION | CROCC, WASF2, DCXR | IDO1 4828/4885KDM4E 2182/4885MEN1 3877/4885 |
| US-12606692-B2 | Spectacle lens | POT1, TCOF1, CRY1 | IDO1 4326/4885KDM4E 1832/4885MEN1 244/4885 |
| US-20260062512-A1 | CURABLE COMPOSITION, CURED PRODUCT, AND METHOD FOR PRODUCING CURED PRODUCT | EHMT1, EHMT2, ASH2L | IDO1 2755/4885KDM4E 117/4885MEN1 4001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.